Drug Type Small molecule drug |
Synonyms Carbon monoxide, carbon(II) oxide, CO + [2] |
Target |
Mechanism HMOX1 modulators(Heme oxygenase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Phase 2 | US | 01 May 2024 | |
Anemia, Sickle Cell | Phase 2 | US | 01 May 2024 | |
Pulmonary Arterial Hypertension | Phase 2 | US | 01 Jul 2012 | |
Pulmonary Arterial Hypertension | Phase 2 | US | 01 Jul 2012 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | US | 01 Jul 2011 | |
Delayed Graft Function | Phase 2 | - | - | |
Parkinson Disease | Preclinical | US | 20 Sep 2023 | |
Multiple Sclerosis | Preclinical | - | - |
Not Applicable | - | HBI-002 10ml/kg | wxdznoatuh(cfylzsspkl) = putpzqggcz clrrlmykuj (gbbgrxqldd ) | Positive | 25 Apr 2023 | ||
Phase 2 | 58 | Inhaled CO at 100 to 200 parts per million | lbcxstqzoj(yyowrdpvts) = aqwrlhtjus ihvsmlfcdb (wejsjhpegw ) | - | 01 Jan 2018 | ||
Phase 2 | 58 | (Carbon Monoxide Inhalation) | nuyowmydzu(eauhquityq) = nyhuxggzym ofdwrsenwx (woqkxyawph, sbtsqevxyd - asnxadzfgg) View more | - | 14 Jun 2017 | ||
oxygen (Oxygen 21%) | nuyowmydzu(eauhquityq) = mujzqzwfwp ofdwrsenwx (woqkxyawph, zieiyxvent - gwcigivryv) View more | ||||||
Phase 2 | 20 | 100-125 ppm CO inhalation | (jzbrhgrzkj) = ndybenjzeq oktciczcdz (eocifkcxve ) | - | 01 Dec 2007 | ||
(Placebo inhalation) | (jzbrhgrzkj) = aszopqsuhz oktciczcdz (eocifkcxve ) | ||||||
Not Applicable | - | 10 | Inhaled Carbon Monoxide (CO) | fsqpftypkv(fphjdksoqp) = whdcrjodql govvxpmzze (cavsgafaqp ) View more | Positive | 01 May 2005 |